- Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
- Zymeworks Announces Participation in Upcoming Investor Conferences
- Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
- Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
- Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
- Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
- Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
- Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
- Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
- Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025
More ▼
Key statistics
As of last trade, Zymeworks Inc (ZYME:NSQ) traded at 9.23, 53.45% above the 52 week low of 6.02 set on Oct 04, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.01 |
---|---|
High | 9.34 |
Low | 8.95 |
Bid | 7.66 |
Offer | 9.29 |
Previous close | 9.23 |
Average volume | 769.62k |
---|---|
Shares outstanding | 70.70m |
Free float | 65.89m |
P/E (TTM) | -- |
Market cap | 652.61m USD |
EPS (TTM) | -1.79 USD |
Data delayed at least 15 minutes, as of May 09 2024 21:00 BST.
More ▼